POPULARITY
Simon and Dan return with the second half of their deep dive into 50 Ways to Invest in the AI Revolution. While Part 1 covered the obvious giants—semiconductors, hyperscalers, pure-play AI software, enterprise apps, and data center REITs—this episode looks at some of the less obvious but equally important beneficiaries of AI. From utilities and grid infrastructure to commodities like uranium, copper, and natural gas, they explore the backbone powering AI’s massive energy demand. They also dig into healthcare, cybersecurity, IT consulting, and industrial automation—sectors where AI is already improving efficiency, margins, and innovation in ways most investors overlook. Once again, they highlight dozens of companies and ETFs across these subsectors, balancing both the opportunities and the risks. If you’re wondering how to get diversified AI exposure beyond the usual suspects like NVDA and MSFT, this episode is packed with fresh angles and ticker ideas. Tickers discussed: Utilities & infrastructure: NEE, CNP, D, CPX.TO, BEPC, BIP.UN.TO, PWR, MTZ, SU, ENB Commodities & energy: TECK.B.TO, TOU.TO, URA, U.UN.TO, UNG, ZEO.TO, BCIM Healthcare: GEHC, SMMNY, PFE, ISRG, WELL.TO, ZHQ.TO Cybersecurity: CRWD, PANW, HAK, CYBR.TOConsulting & IT services: ACN, IBM, INFY Industrial automation: ROK, ABB, PNG.V Check out our portfolio by going to Jointci.com Our Website Our New Youtube Channel! Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Fiscal.ai for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense. See omnystudio.com/listener for privacy information.
欢迎收听雪球出品的财经有深度,雪球,国内领先的集投资交流交易一体的综合财富管理平台,聪明的投资者都在这里。今天分享的内容叫英伟达的护城河,来自古董鱼。看了一晚上英伟达的护城河,强行洗脑,最后的结论是英伟达不倒,我不撤退,一直AI下去。如果哪天英伟达被颠覆了,别问我还能不能拿,因为那时候我已经跑了。大家都以为英伟达的硬件强,其实它的隐形护城河是计算平台和编程模型加网络。我们来看看英伟达的先发优势与成熟度:他的计算平台和编程模型于 2007 年推出,经过近 20 年的发展,已成为 G P U 计算的行业标准。它积累了超过 400 万开发者,形成了庞大的社区和网络效应。从英伟达的全栈优化与工具链来看,计算平台和编程模型提供了从编译器、调试器到高度优化的核心库的全套工具。这些库经过英伟达的深度优化,能充分发挥其硬件性能,开发者无需编写底层代码即可获得顶尖性能。再从开发习惯与迁移成本来看,计算平台和编程模型广泛纳入大学课程和培训项目,工程师们从小白阶段就开始接触它。企业积累了大量的 CUDA 代码和专业知识,切换到其他平台需要重写代码、重新培训员工,并面临性能不确定的风险,这种切换成本高得难以想象。这种计算平台和编程模型的关键优势之一是,随着时间的推移,它通过新的软件更新不断改进硬件。刚刚对在H100和新的Blackwell GB200 NVL72这两种版本的芯片上运行AI训练进行了基准比较,结果表明了为什么计算平台和编程模型及其软件随着时间的推移的改进如此重要。最新,CoreWeave公司给出的数据,对 NVIDIA GB300 NVL72,进行了基准测试,其每 4x的 G P U 的单位时间内跑AI的速度比16x的H100高6倍,最初可不是这个比值,通过英伟达的计算平台和编程模型的不断优化,最后达到了这个高性能。其实一直有用CUDA转换器的,然而,用过转换器的,他们以大约80%的速度转换CUDA代码,而剩下的20%必须由内核工程师手动完成,这样成本并不便宜。同样有趣的是,虽然其他公司正在结成联盟,为Nv的全栈部分建立替代方案,但是目前没有一个与英伟达竞争的联盟出现。接着是英伟达网络的护城河。关于网络,通常说纵向扩展和横向扩展这两个部分,最近火的scale across先不提了。纵向扩展指的是机架里的 G P U 能够相互连接,形成单个 G P U 节点,并使其尽可能强大。然后,横向扩展网络使这些 G P U 节点能够连接到其他 G P U 节点,并共同形成一个大型 G P U 集群,使用其专有的 N V Link和 N V switches横向扩展时,他们使用从Mellanox收购中获得InfiniBand或以太网作为次要选项。英伟达的其他对手一起搞了个 U A link联盟,它的成员包含了能想到的其他公司。U A link有 A M D 、亚马逊、谷歌、英特尔、Meta、微软、思科、苹果、Astera Labs等公司组成。但它对 A M D 来说很重要,因为与英伟达相比,其最大的缺点之一是网络。网络不仅对培训人工智能工作负载很重要,而且对推理也很重要。随着推理模型的推论变得更加复杂,拥有良好的放大和缩小是关键。同时,为了解决这一挑战,他们希望支持所有可用的替代方案。这就是为什么他们有灵活的输入输出通道。这些灵活的输入输出通道使A M D能够支持不同的标准。虽然 U A Link还很年轻,但它已经遇到了很大的挫折。起初,博通是参与的关键公司之一,但后来退了。这是一个重大的挫折,因为 A M D 现在必须依靠AsteraLabs和Marvell来生产 U A Link联盟的交换机,而 U A Link交换机要到2027年才能准备就绪。这就是为什么我们可以看到,虽然 A M D 的MI400x显卡有 U A Link Serdes,但它并没有构成一个完整的扩展网络。不过,英伟达不仅仅是在关注这一发展,因为在UALink 1.0发布一个月后,他们宣布了NVLink Fusion,从纸面上看,它打开了NVLink生态系统。这对英伟达来说是一大步,因为一位前英伟达高级员工解释说,在内部实施这一步骤是多么具有挑战性,因为Meta想在他在那里工作时将 N V Links用于他们的MTIA,而英伟达的回答是坚定的“不”。NVLink 技术模块是用英伟达自家独有的方式和芯片传递数据的,其中一部分技术至今还是英伟达独有的。有了这套技术,英伟达只能让客户用他们的芯片间连接技术。现在客户也意识到了这一点,就像那位前英伟达员工提到的,他们担心这样一来,就算自己有定制的专用芯片ASIC,也会进一步被绑在英伟达的生态系统里 ,所以 U A Link到现在依旧是个替代选择。英伟达和 U A Link这边,有个关键角色是 Astera Labs公司 —— 毕竟现在博通已经自己单干、走自己的技术路线了。现在 U A Link联盟得靠 Astera Labs 来提供交换机。英伟达很清楚Astera Labs现在是 U A Link联盟里的核心部分,可能会想办法促使Astera Labs订购更多英伟达的 NVLink Fusion;而一旦Astera Labs用了NVLink Fusion,他们能为 U A Link服务的能力就会受限,至于这么做最终能不能帮到英伟达,还得靠时间来验证。在横向扩展方面,英伟达的InfiniBand网络技术,有个替代方案是支持远程直接内存访问的以太网。英伟达也支持这个替代方案,但只把它当作“次要选项”,英伟达甚至还有个 Spectrum X 以太网平台,因为他们通过收购,拿到了Spectrum系列交换机的技术和产能。很多大型科技公司也支持以太网,原因很实在:它成本更低,早就广泛用在数据中心里,而且有多家供应商可选。现在支持 RDMA 的以太网已经获得了不少采用度,因为大型科技公司和Meta这类企业,都愿意用它来减少对英伟达的依赖。不过,此前我们虽已探讨过纵向扩展和横向扩展软件与网络这两个核心层面,但还有一个新的关键层面才刚刚兴起,那就是HBM,高带宽内存。作为人工智能加速器的核心组件之一,HBM的重要性会随着AI模型向更大规模、更复杂结构发展,而愈发凸显。目前,海力士与美光是 HBM3 内存的主要供应商,不过三星预计也将完成相关认证流程,加入 HBM3 的供应体系。当向HBM4内存过渡时,将迎来一项关键变革:HBM4 的基础芯片晶圆需采用先进的逻辑芯片制造工艺。这意味着海力士与美光无法独立完成,必须将制造环节外包给台积电;同时,这些内存厂商还需与逻辑芯片设计公司或技术授权商展开合作,方能完成它的设计工作。这一变革为 “定制化 HBM 内存方案” 创造了空间,但反过来也意味着,HBM4的利润需与台积电共享一部分 —— 毕竟其制造环节高度依赖台积电。此外,HBM4 的复杂度远高于HBM3,需将内存厂商的芯片堆叠技术与代工厂的先进制造工艺相结合,这种局面实际上对英伟达更为有利,因为英伟达此前已计划自主设计HBM4的 3 纳米芯片裸片。事实上,我并不担心专用芯片ASIC会侵占过多市场份额。多数云服务提供商选择自主研发芯片,主要源于英伟达的市场垄断与显卡产能不足 —— 这实属无奈之举,他们为了更快获取可用算力,才不得不走上自主研发之路。此次英伟达发布的 Rubin 系列 CPX 产品,核心目标便是提升 AI 的上下文推理能力。在我看来,推理领域真正的领先者,并非 ASIC 这类专用推理芯片,仍属英伟达的产品。另有一项关键问题不容忽视:数据中心可使用的电力存在限制,尤其在北美地区,电力更是必须重视的硬性约束。为何 X AI 公司能在 122 天内建成全球规模最大的算力中心?一方面,马斯克拥有全球顶尖的工程团队与执行能力;更重要的是,X AI所能获得的供电支持,在全球范围内也处于顶尖水平。当你运营现有数据中心,或计划新建数据中心时,需与电力公司合作确定固定的电力使用额度,而这一额度具有明确上限 —— 你无法随意致电电力公司,提出 “需额外增加 10% 电力” 的需求。若我们对比英伟达当前一代与下一代服务器,那么在评估H100与GB300服务器时,核心衡量标准应是 “处理同等数量的令牌时,可节省多少电力”。而英伟达每次产品更新,实际上都在推进这项电力效率优化工作。所以,我想说的是英伟达的手里牌很多,老黄这个人能力强的可怕,就算现在出来ASIC和其他 G P U 竞争对手,都是更多跟随和模仿,对所有在供应链做硬件的公司都是利好,因为总的需求变多了,可以说遍地开花。
In this episode, Ben Bajarin and Jay Goldberg discuss the recent Apple iPhone launch event, highlighting the innovations in the iPhone Air and Apple's semiconductor strategy. They delve into Synopsys's disappointing earnings report and the subsequent market reactions, as well as Broadcom's position in the semiconductor landscape. The conversation also covers Nvidia's new CPX system and the implications for the market, concluding with a discussion on the funding of the AI boom and the financial strategies of major players like Oracle and OpenAI.
Send us a textToday we welcome Max Jeganathan as he discusses his book 'The Freedom Trap', exploring the concept of freedom in relation to everyday decision-making. He distinguishes between freedom and autonomy, emphasizing the importance of understanding their differences. The discussion delves into historical perspectives on freedom, the Christian viewpoint on autonomy, and the various traps associated with freedom, including being trapped by choice, consequences, success, and technology. The conversation highlights the need for responsibility in exercising freedom and the impact of societal expectations on individual choices.You can purchase The Freedom Trap at all major Christian book stores.You can find Max over on instagram https://www.instagram.com/primaxjeg/or at CPX https://publicchristianity.org/about/meet-our-speakers/Follow @hertheology on Instagram & YouTube. Head to hertheology.com to find out more.
The Moose on The Loose helps Canadians to invest with more conviction so they can enjoy their retirement. Today we are taking a look at how to build a portfolio with 4%+ yield: T. CTC.A. PEP CNQ, EPD, CVX, ENB or TRP CM, GWO, SLF, TD LIF CRT, VICI, O, GRT BEP, BIP, EMA (or CPX) more risky: MG, GIS, MO, TGT, ARE Get your Investment roadmap: https://dividendstocksrock.com/roadmap Download the Rockstar list here: https://moosemarkets.com/rockstars Join the Retirement Loop waitlist here: https://www.retirementloop.ca Why I prefer low yield vs high yield: https://moosemarkets.com/income
The Moose on The Loose helps Canadians to invest with more conviction so they can enjoy their retirement. 5 easy steps to clean your portfolio: https://moosemarkets.com/webinar Download the Rockstar list here: https://moosemarkets.com/rockstars Join the Retirement Loop waitlist here: https://www.retirementloop.ca Why I prefer low yield vs high yield: https://moosemarkets.com/income Companies mentioned in this episode: TFII.TO, HPS.A.TO, CPX.TO, CCO.TO, ADEN.TO, JWEL.TO, CNQ.TO, NA.TO
A talk given by Morten Sørensen on Network Segmentation at CPX 2025 in Vienna.
Episode 22: 2 April 2025Simon Smart talks to Max Jeganathan about his new book - the the latest in the Re:Considering series from CPX and Acorn Press.Check out the Re:Considering websiteOrder the book from Koorong or AmazonInstagram: Check out Max and Simon on Instagram at @primaxjeg and @simonsmartcpxProducer: Allan Dowthwaite
Newly diagnosed acute myeloid leukemia (AML) is traditionally treated with intensive chemotherapy for eligible patients, but ongoing research is exploring... The post Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more! appeared first on VJHemOnc.
An excerpt from a session with Danny Jung, Cyber Security Evangelist at SITS Group at CPX 2025 Vienna: Maestro for Everyone!
I talk about the highlights from CPX 2025 and include a mention to our upcoming Be Your Own TAC Part Deux session for EMEA and Americas on 27 March 2025!
La Dra. Nidia Paulina Zapata Canto, hematóloga adscrita al Instituto Nacional de Cancerología en la Ciudad de México, presenta un análisis de los estudios más relevantes del año 2024 en el ámbito de la hematología. Mieloma múltiple DREAMM-7: Estudio fase III, global, aleatorizado 1:1, y abierto en el cual se comparó la eficacia y seguridad de belantamab mafodotina, bortezomib y dexametasona (BVd) vs. daratumumab, bortezomib y dexametasona (DVd) en pacientes con mieloma múltiple que habían presentado progresión después de al menos una línea previa de tratamiento. Leucemia linfocítica crónica EPCORE CLL-1: Estudio fase Ib/II, multicéntrico, abierto que evaluó la seguridad y eficacia de epcoritamab. Se incluyeron pacientes con LLC CD20+ refractario/recaída que requerían tratamiento y ≥2 líneas de tratamiento sistémico previas, incluido el tratamiento con o intolerancia a un BTKi. Leucemia mieloide crónica ASC4FIRST: Estudio fase III, aleatorizado que comparó asciminib con todos los inhibidores de tirosina cinasa estándar en el tratamiento de la leucemia mieloide crónica en fase crónica recién diagnosticada. Se analizaron los resultados primarios de eficacia, así como datos adicionales de seguridad y tolerabilidad de asciminib frente a cada TKI a partir del análisis primario con el corte de datos de la semana 48. Linfoma del manto ECOG-ACRIN EA4181: Estudio fase III, aleatorizado 1:1:1 que comparó 1. Bendamustina, rituximab y citarabina en dosis altas 2. Bendamustina, rituximab, citarabina en dosis altas y acalabrutinib y 3. Bendamustina, rituximab y acalabrutinib en pacientes ≤70 años con linfoma de células del manto sin tratamiento. Leucemia mieloide aguda AML19: Estudio que realizó una comparación aleatorizada de CPX-351 y FLAG-Ida en pacientes con leucemia mieloide aguda de alto riesgo/síndrome mielodisplásico (SMD) y mutaciones genéticas relacionadas con SMD. Fecha de grabación: 14 de enero de 2025. Todos los comentarios emitidos por los participantes son a título personal y no reflejan la opinión de ScienceLink u otros. Se deberá revisar las indicaciones aprobadas en el país para cada uno de los tratamientos y medicamentos comentados. Las opiniones vertidas en este programa son responsabilidad de los participantes o entrevistados, ScienceLink las ha incluido con fines educativos. Este material está dirigido a profesionales de la salud exclusivamente.
What does the Christmas promise of “peace on earth” mean in the face of human suffering, natural disasters, and other heartbreaks that are part of all our lives?Twenty years ago, the Indian Ocean tsunami claimed the lives of some 225,000 people, after battering the coastlines of India, Indonesia, Malysia, the Maldives, Myanmar, Sri Lanka, Seychelles, Thailand, and Somalia.Tim Costello, then CEO of World Vision, was among the first to be on the ground in Sri Lanka, which was among the countries worst affected. He recounts being confronted with the mammoth scale of devastation on the ground and the tragedy of so many lives lost. Then we hear from former CPX-er Mark Stephens, now Lecturer in New Testament at Sydney Missionary Bible College, about what the Christmas promise of “peace on earth” could possibly mean in the face of untold human suffering – and what are the grounds of hope now and into the future.This is our last episode of Life & Faith for the year but we will be back in 2025. From the whole team at CPX, we wish you a Merry Christmas.
This week on the php podcast, Eric and John talk about Lazy Object in PHP 8.4, php[tek] 2025 first round of speaker selection is done, PHP Architect is now on Bluesky (@phparch.com), join the PHP Architect Squad on daily.dev. CPX, Security issues with RCS, and more… Links from the show: PHP: Lazy Objects – Manual […] The post php[podcast] 2024.12.5: Tek(nically) Speaking appeared first on php[architect].
Tim Winton talks to Life & Faith about his new novel Juice.Tim Winton is one of Australia's most loved writers. He is also well-known as an environmental activist and defender of landscapes and fragile ecosystems. And now, as a grandfather to 6 children, he is clearly deeply concerned about what we might be leaving behind to them and those who come after them.His lates novel, Juice, is set in the distant future, a time when climate catastrophe has wreaked havoc on the globe. Civilisation has crumbled. Huge parts of the earth, in a band emanating from the equator, are completely uninhabitable. It's all about the global unravelling that could accompany climate devastation. It's frightening and sobering. And yet somehow determinedly hopeful.Tim came into the CPX studio to talk about Juice and what inspired this challenging piece of art. Explore:Tim Winton's novel Juice Ningaloo NyingguluSimon Smart's review of Juice at ABC Religion & EthicsTell us what you think of Life & Faith in this 5-minute survey
Life & Faith producer, Allan Dowthwaite, takes over the studio to mark 500 episodes of amazing conversations.Allan Dowthwaite, CPX's media director, normally runs the recording studio for the team. But in this special episode, marking twelve-and-a-half years of the podcast, he's commandeered the mic as your personal guide to Life & Faith's greatest conversations, organised into the following categories for your listening pleasure.Links are included to any episode you want to listen to in full.The cultural waters in which we swim, featuring Sydney Morning Herald Economics Editor Ross Gittins, political scientist Dale Kuehne, New York Times film writer Alissa Wilkinson, cultural critic Andy Crouch, and author Tim Winton.How Christianity explains our world, featuring cold case detective Jim Warner Wallace, author Marilynne Robinson, author Francis Spufford, and historian Tom Holland.Surprising stories, featuring Oxford mathematician John Lennox, Alex Gaffikin, who wintered on Antarctica for two years, Johnnie Walker, beloved authority on the Camino de Santiago, and the late scholar of African-American religion, Albert J. Raboteau.Indigenous Australians, featuring Yorta Yorta man William Cooper, Torres Strait Islander leader and pastor Gabriel Bani, and Aunty Maureen Atkinson, member of the Stolen Generation.Changing one's mind about faith, featuring ABC Religion & Ethics editor Scott Stephens and author Susannah McFarlane.Ordinary people, extraordinary acts, featuring Australian nurse Valerie...
Summer rhymes with more time outside, pool parties or sunset walks, but it's actually a good time to benefit from the opportunities on the market while it's a little more quiet. Interested in CWB.TO, STN.TO, TIH.TO, CPX.TO, or DOL.TO? Dive in with us! Download the Dividend Income for Life Guide. Make sure to check out the complete show notes. Twitter: @TheDividendGuy FB: http://bit.ly/2Z7Q5gF YouTube: http://bit.ly/2Zs6r1r DividendStocksRock.com
Bill Bennett, director of the film The Way, My Way and Camino legend Johnnie Walker Santiago reflect on the spiritual riches of going on pilgrimage. “I see this walk as an 800km long cathedral”. So says Australian filmmaker Bill Bennett in the film The Way, My Way, which depicts Bill's experiences walking the Camino de Santiago.The Camino de Santiago, or the Way of St James, is a network of pilgrimage roads and paths running through Spain, France, and Portugal, leading to the cathedral at Santiago de Compostela in Galicia in north-western Spain, long believed to be the burial place of the Apostle James.The Camino has been an oft-travelled pilgrimage route since medieval times. These days, plenty of spiritual seekers like Bill, and others looking for connection and adventure, become modern-day pilgrims, driven to discover deeper truths about life along the way.This episode of Life & Faith interviews Bill Bennett, the director of The Way, My Way as well as Johnnie Walker Santiago, a beloved expert and authority on the Camino de Santiago. ---Explore:Trailer for The Way, My Way The book Bill Bennett wrote, upon which the film is based: The Way, My Way: A Camino memoir Johnnie Walker Santiago's guidebooks: Camino to Santiago: A spiritual companion and It's About Time: A call to the Camino de Santiago Check out CPX's new podcast, The Week @ CPX
This dreaded disease seems to strip away everything that makes us, well, us. A chaplain and a psychiatrist remind us of the human at the centre of the diagnosis.---The ‘d' word – dementia – is one that everyone fears. It seems to strip away everything that made that person with the disease the person we once knew. It's easy to lose sight of the person, the human at the centre of the diagnosis.Today, 420,000 Australians live with dementia, a number projected to double in the next 30 years, which makes it a significant and growing health challenge for Australia's ageing population.This episode of Life & Faith brings you two conversations that bring the human at the centre of the dementia diagnosis back into focus. We're featuring two interviews Natasha Moore did before going on maternity leave: with Neil Jeyasingam, Clinical Associate Professor of Psychiatry at the University of Sydney. Neil is also a CPX Associate. Natasha also spoke to Ben Boland, a chaplain with 15 years' experience in residential aged care – and whose father lives with dementia. Explore:Dementia Australia, the national peak body representing people with dementia, their families, and carers. Check out CPX's new podcast, The Week At CPX, to keep up-to-date with everything that's happening at CPX, plus a bit of commentary on the side.
Mercy Aiken tells Life & Faith of the joy-filled, yet painful life of Palestinian Christian, Bishara Awad.Bishara was a child in Jerusalem when his father was shot and killed during the Israeli-Arab war of 1948. The story of his life and that of his family provides a sobering portrait of life in Israel/Palestine during decades of war, violence, tension and dashed dreams for those seeking a peaceful resolution to conflict.Somehow, Bishara, a Palestinian Christian and community leader, remains unbowed, but also forgiving and empathetic towards his opponents. His story is told in the book, Yet in the Dark Streets Shining – a Palestinian Story of Hope and Resilience in Bethlehem. The coauthor of the book is Mercy Aiken – who came into the CPX studio. Mercy was in Australia with the Palestine Israel Ecumenical Network.The book: Yet in the Dark Streets Shining – a Palestinian Story of Hope and Resilience in BethlehemPalestine Israel Ecumenical Network
In this week's episode, we'll discuss gut microbiota exploitation by CPX-351 in acute myeloid leukemia. Then we'll learn about optimizing anti-myeloma immunity. New research shows that regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation. Finally we'll discuss among pediatric patients with ITP or other autoimmune cytopenias, which ones will go on to develop systemic lupus? Featured Articles: CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasisRegulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantationAntinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus
A brief overview of the product announcements made at CPX 2024. The materials are available on CheckMates: https://community.checkpoint.com/t5/General-Topics/CPX-2024/m-p/208174#M34494
Asuntha Charles has lived in some toughest places in the world. And she's loved it. Long As a young woman, Asuntha Charles stubbornly defied her culture to advocate for vulnerable women and girls. That determination never left her as she dedicated her life to voiceless people in not only her native India, but places like Afghanistan, Bangladesh, Sudan and Iraq. Here she tells Life & Faith about her extraordinary life of service and care for people who needed that care most. And we also get an insight into the early influences that shaped her life and contributed to her holding a faith that sustains her even in the face of risk, and heartbreaking losses. Try listening to this and not be challenged and inspired! --- Sign up for the CPX newsletter here
War correspondent Janine di Giovanni has covered the near-extinction of the ancient Christian communities of the Middle East. --- “They've survived plagues, they've survived pillages, they've survived raids, they've survived purges – and they most recently survived ISIS.” The Christian communities of the Middle East – in places like Iraq and Syria, Egypt and Palestine – are ancient, and over recent decades have been facing various kinds of existential threat. Janine di Giovanni's book The Vanishing: The Twilight of Christianity in the Middle East is a work of “pre-archaeology”, recording the stories and courage of these communities even as they disappear. Di Giovanni is a war correspondent and human rights investigator who has covered 18 wars and 3 genocides across her career, bearing witness to the terrible things that happen in our world. In this episode, she talks about visiting churches in war zones, why people stay, and whether faith – including her own belief in God – is strong enough to survive war. She also shares a bit about her current work with The Reckoning Project, a war crimes unit working within Ukraine. “It's been an honour to work for 35 years in all these war zones with these extraordinary people. I feel very privileged and lucky every day of my life that I do this work, because … I have a purposeful life.” --- EXPLORE: The Vanishing: The Twilight of Christianity in the Middle East, by Janine di Giovanni The Reckoning Project Sign up for the CPX newsletter here
CPX writers talk about how they're hoping to breathe new life into a very old story. --- Get a glimpse into the CPX writers' room as Simon, Natasha, Justine and Max talk about what they're writing about Easter, or how they go about working out how to write about Easter. Natasha talks about American novelist Marilynne Robinson's new book Reading Genesis and how Robinson's courteous and unapologetic way of doing “public Christianity” messes with how public conversations about God usually happen. Max discusses how we may admire heroes for their greatness – like Homer's Achilles, for example – but we really long for goodness, expressed by saviours who willingly sacrifice themselves for others. Simon discusses how a quirk of the calendar can put Anzac Day and Easter in proximity to each other, bringing those two events and their focus on sacrifice into conversation. Justine talks about death denial among the tech titans of Silicon Valley who hope to solve the problem of death. She argues that they express what life feels like if Easter Saturday – the day Jesus lay dead in the grave – is never followed by Easter Sunday – the day that changed everything, according to the Christian faith, because it is the day that Jesus rose to new life. --- Explore: Natasha's piece on Marilynne Robinson's Reading Genesis An article Simon wrote linking Anzac Day with Easter Sign up for the CPX newsletter here
We explore the spiritual needs of people in intensive care in hospital, or behind bars. --- “I went to see this lady and as soon as I walked in, she actually said, ‘f*** off, I don't want to have anything to do with you people'.” Chaplaincy in Australia is contested. If people have had a bad experience with the church or concerned that someone might be trying to manipulate them, a chaplain walking up to say hi might get that response. Not least because people can be very vulnerable if they're dealing with a shocking medical episode in hospital or grappling with life in prison. This Life & Faith episode takes you behind the scenes of two very different environments: the intensive care unit of a major Sydney hospital, and Kirkconnell Correctional Centre in regional NSW. Two chaplains from Jericho Road, a social service organisation linked with the Presbyterian Church in NSW, tell us about what it's like to care spiritually for people during very difficult times in their lives. Content warning: there are some challenging stories told in these interviews. This episode is not suitable for children. --- Explore: Jericho Road's Love Your Neighbour course on chaplaincy Sign up for CPX's regular email newsletter to find out more about our work.
…of which CPX's Justine Toh is first and foremost. --- In the lead up to Easter, Justine is giving up not only sugar, but her ignorance about all things Lent. She speaks to Catholic theologian Matt Tan, who goes by Awkward Asian Theologian on socials, about Lent and its three-fold focus: giving up, alms-giving, and prayer. They discuss the difficulty of self-sacrifice and the way that, strangely enough, it often proves the easier option over alms-giving, which needn't only include giving to charity, but also intentional, active investment in the lives of others. Matt also alludes to the way church seasons induct the believer into an entirely different order of time. He cites the work of Neil Postman, who said the clock was originally invented to help monks keep to their daily prayer schedule. In time, however, the clock, went beyond the monastery and conquered the rest of the world. Time is now subdivided into increasingly minute moments that all need to be filled. So, what does it mean to live according to the rhythms of sacred time? --- Explore Simon Smart's Ash Wednesday article Life & Faith episode with Matt Tan on the metaphysics of pornography Follow Awkward Asian Theologian on Instagram
20 years on from the founding of Facebook, what role do these platforms play in our lives? --- February 4 marked 20 years since Mark Zuckerburg launched the site that was initially known as The Facebook from his Harvard dorm room, so this seems like a good time to take stock of what social media now looks like, and what our lives look like as a result. Whether you're an avid user of Facebook, Instagram, Twitter/X, TikTok, and more, or a social media sceptic, join Simon Smart, Justine Toh, and Natasha Moore for a frank chat about the better and worse of these platforms in 2024. With cameos from Andy Crouch, CPX brand manager (and socials pro) Clare Potts, and recent social media quitter Jess Forsyth, the discussion ranges from whether group chats count as social media to whether the internet is “made of demons” - as well as the advantages (and disciplines) of being an iceberg vs an ocean liner. --- EXPLORE: New York Times article How Group Chats Rule the World Philippa Moore's article about quitting social media Paul Kingsnorth's Substack essays The Universal and The Neon God Alan Jacobs' New Atlantis piece Andy Crouch's Spiritual Practices for Public Leadership
Reviewing some of the top cyber security stories for 2023. Hope to see everyone at CPX 2024!
Our cultural narrative says there is no supernatural or transcendent realm. The CPX team wants to break that spell. --- Seen & Heard is back – and this time, the team have disenchantment in their sights, or the belief that there is no more supernatural or transcendent realm to life, that science is the only verifiable path to truth, and that all things religious are debunked, once and for all. But is this true? The books and films we've been reading and watching might disagree. Natasha highlights beloved Australian author Helen Garner's encounter with an angel and our flirtation with the supernatural through occasions like Halloween, before taking us through the supernatural stylings of the latest Poirot film A Haunting in Venice, based (extremely loosely) on Agatha Christie's 1969 novel Hallowe'en Party. Simon has been reading the biography of tennis icon and former World No. 1 Andre Agassi who, it turns out, hated tennis and wrestled with fame, but discovered that helping people is the “only perfection there is”. A world that has cast off religion and the transcendent also leaves behind any account of the good life that goes along with those claims. Yet Agassi discovered that being the best tennis player in the world didn't fulfil him. Only serving others did, which resonates with the Christian claim that the good life is a life lived for others. And Justine raves about Susannah Clarke's novel Piranesi and its vivid portrayal of what the disenchanted view of the world lacks: wonder, deep communion with the world, joy, and hope. Plus, Justine makes a bold claim: Susannah Clarke is the 21st-century successor to C.S. Lewis. -- Explore Helen Garner describing her angelic encounter at the 2018 Sydney Writers' Festival (from 30 mins) Sean Kelly's column mentioning Hilary Mantel's possibly demonic encounter Trailer for A Haunting in Venice Natasha's article on Halloween, published in the Sydney Morning Herald Andre Agassi's Open: An Autobiography The Guardian's interview with Susannah Clarke Piranesi by Susannah Clarke Wikipedia entry on the real-life Piranesi, the 18th-century architect and artist
Featuring perspectives from Dr Naval Daver, including the following topics: Introduction: Biology, Classification, p53, Magrolimab (0:00) Case: A man in his early 70s with acute myeloid leukemia (AML) with a TP53 mutation, myelodysplastic syndromes (MDS)-related changes and complex cytogenetics who received CPX-351receives azacitidine/venetoclax and is now in palliative care — Anna Halpern, MD (9:06) Case: A woman in her late 50s with multiple comorbidities and FLT3-ITD-positive AML who experienced disease progression on azacitidine/venetoclax now receives gilteritinib — Bhavana (Tina) Bhatnagar, DO (17:01) Case: A woman in her early 70s with AML with FLT3-ITD and IDH1 mutations receives a hypomethylating agent with ivosidenib — Amany R Keruakous, MD, MS (29:10) Case: A man in his early 60s with newly diagnosed MDS with ring sideroblasts receives oral decitabine/cedazuridine — Khuda Dad Khan, MD, PhD (33:54) Case: A man in his mid 60s presents with copper deficiency and ring sideroblasts; genetic analysis reveals SF3B1 and DNMT3A mutations — Rachel J Cook, MD (42:25) Case: A woman in her early 70s with a history of extensively treated follicular lymphoma develops AML and receives CPX-351 — Ranju Gupta, MD (46:05) Case: A woman in her late 70s with newly diagnosed AML receives decitabine/venetoclax with concurrent voriconazole — Rebecca L Olin, MD, MSCE (51:05) Case: A woman in her late 90s is diagnosed with multiple myeloma and del(5q) MDS — Erik Rupard, MD (54:26) Journal Club with Dr Daver (57:28) CME information and select publications
#circuitpythonparsec Use the Circuit Playground library on the CPX and CPB boards to easily control on-board NeoPixels. Learn about CircuitPython: https://circuitpython.org Code examples here: https://github.com/jedgarpark/parsec/blob/main/2023-07-27/code.py Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------
#circuitpythonparsec Use the Circuit Playground library on the CPX and CPB boards to detect single and double taps with the on-board accelerometer. Learn about CircuitPython: https://circuitpython.org Code examples here: https://github.com/jedgarpark/parsec/blob/main/2023-07-13/code.py Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------
#circuitpythonparsec Use the Circuit Playground library on the CPX and CPB boards to light the LED and use the switch. Learn about CircuitPython: https://circuitpython.org Code examples here: https://github.com/jedgarpark/parsec/blob/main/2023-07-06/code.py Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------
We start this episode by talking about TD's Investor Sentiment Index and which stocks were the most bought and sold according to TD's data. We then look at data showing that the yield between equities, bonds and US treasuries is almost identical. We finish the episode by looking at the TSX return this year and the best performing TSX stocks over the last 5 years. Symbols of stocks discussed: TD.TO, ASE.TO, PMET.TO, FIL.TO, WELL.TO, BLU.TO, HWX.TO, KNT.TO, FOM.TO, CS.TO, TSU.TO, XENE.TO, SLI.TO, IVN.TO, LAC.TO, OLA.TO, RUP.TO, SHOP.TO, TFII.TO, NOA.TO, TRI.TO, GSY.TO, EQB.TO, CSU.TO, HCG.TO, ATS.TO SVI.TO, ATD.TO, ATZ.TO, L. TO, IFC.TO, CPX.TO, UNS.TO, ENB.TO, TSLA, SU.TO, NVDA, BNS.TO, CM.TO, BMO.TO, RY.TO, AC.TO, AMD, AAPL, AMZN Symbols of ETF discussed: XIC.TO, VFV.TO, VSP.TO, RSP, XFN.TO, XEG.TO, ZIN.TO, XMA.TO, XIT.TO Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon's twitter: @Fiat_Iceberg Braden's twitter: @BradoCapital Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Sign up to Stratosphere for free
The CPX team freaks out about AI, explores stories of “efficiency” run amok, and probes our tech utopias. --- The apocalypse will be ... boring. Or so says Charlie Warzel, tech journalist for The Atlantic. He means that AI won't put you out of a job or take over the world, so much as overstuff your inbox and give you more mind-numbing tasks to complete. Other people in the know about AI are less optimistic. Geoffrey Hinton, the “godfather” of AI who resigned from Google in May, Sam Altman, the CEO of the company behind ChatGPT, and others have sounded the alarm: AI is progressing too quickly, no one knows exactly how it works, and without careful regulation it will upend life as we know it. There are a lot of unknowns where technology is concerned. One thing we do know, though, is it makes for great TV, and stories and books. In this edition of Seen & Heard, the CPX team debriefs on what they've been watching and reading. Natasha takes us through the twists and turns of Amazon Prime's Mrs Davis, a “bonkers” show about a nun facing off against Mrs Davis, the all-knowing algorithm against whom she has a grudge. Simon looks at the way George Saunders' short story “Escape from Spiderhead” (and the Spiderhead film based on it) explores how “the greater good” is used to justify all kinds of evils. Justine looks closer at the digital utopia on offer in Grace Chan's speculative novel Every Version of You, and finds that its promise of agelessness, no death, no suffering, and no body is basically heaven without God. Explore: ABC article on Replika Every Version of You by Grace Chan Escape From Spiderhead by George Saunders (via The New Yorker) Mrs Davis trailer Her and a Disembodied Future by Mark Stephens Andy Crouch's Richard Johnson Lecture on why technology keeps disappointing us and Q&A Charlie Warzel: Here's how AI will come for your job
Socially Responsible Stocks To Buy includes the following articles: “10 Best Socially Responsible Stocks to Buy According to Analysts,” by Fahad Saleem; “Top Infrastructure Stocks - From An Engineer's Perspective,” by Financial Engineering; “Top Utilities Stocks for May 2023, by Noah Bolton; “3 Sustainable Investing Stocks to Buy for Socially Responsible Gains,” by Joel Baglole Transcript & Links, Episode 106, May 19, 2023 Hello, Ron Robins here. So, welcome to my podcast episode 106 titled “Socially Responsible Stocks To Buy.” It's presented by Investing for the Soul. Investingforthesoul.com is your site for vital global ethical and sustainable investing mentoring, news, commentary, information, and resources. And look at my newly totally revised website at investingforthesoul.com! So, remember that you can find a full transcript, and links to content – including stock symbols and bonus material – on this episode's podcast page located at investingforthesoul.com/podcasts. Now if any terms are unfamiliar to you, simply Google them. Also, a reminder. I do not evaluate any of the stocks or funds mentioned in these podcasts, nor do I receive any compensation from anyone covered in these podcasts. Furthermore, I will reveal to you any personal investments I have in the investments mentioned herein. Additionally, quotes about individual companies are brief so that I can get as many companies covered as possible in the time allowed. Please go to this podcast's webpage for links to the actual articles for more company and stock information. Also, some companies might be covered more than once and there are also 7 article links below that time didn't allow me to review them here. ------------------------------------------------------------- 1) Socially Responsible Stocks To Buy I'm starting with this article titled 10 Best Socially Responsible Stocks to Buy According to Analysts by Fahad Saleem. Article found on insidermonkey.com. Here are a few of Mr. Saleem's quotes on each of his picks. “For this article we first scanned the Vanguard FTSE Social Index Fund Investor Shares (VFTSX) which seeks to track the performance of the FTSE4Good US Select Index… The fund… uses ESG criteria to screen stocks. We picked 10 stocks which have a strong upside potential based on their average analyst price targets. 10. The Home Depot, Inc. (NYSE:HD) Number of Hedge Fund Holders: 62 Analyst Price Target: $340 The Home Depot also mentions its ESG goals and ESG-related plans on its website. 9. Costco Wholesale Corporation (NASDAQ:COST) Hedge Fund Holders: 66 Analyst Price Target: $545 Last year, Costco voted in favor of a proposal put forward by Green Century Capital Management which suggested that the company should set targets for reaching net-zero greenhouse gas (GHG) emissions. 8. NIKE, Inc. (NYSE:NKE) Hedge Fund Holders: 71 Analyst Price Target: $138 NIKE's slogan in the ESG space is ‘Move to Zero,' which shows its commitment to becoming carbon neutral. 7. Pfizer Inc. (NYSE:PFE) Hedge Fund Holders: 75 Analyst Price Target: $46.50 Pfizer plans to achieve the Net-Zero Standard by 2040. 6. Tesla Inc. (NASDAQ:TSLA) Hedge Fund Holders: 91 Analyst Price Target: $186.20 Despite short-term headwinds, analysts believe Tesla has a lot of room to run. 5. NVIDIA Corporation (NASDAQ:NVDA) Hedge Fund Holders: 106 Analyst Price Target: $355 NVIDIA Corporation has pledged to use advanced technologies to fight the climate change problem… NVIDIA plans to source 65% of its global electricity from renewable sources by 2025. 4. UnitedHealth Group Inc. (NYSE:UNH) Hedge Fund Holders: 110 Analyst Price Target: $600 UnitedHealth Group Inc.'s ESG risk score is 15.3, according to Sustainalytics, which comes under the low risk category. 3. Visa Inc. (NYSE:V) Hedge Fund Holders: 177 Analyst Price Target: $300 A strong ESG score and investments in the ESG space makes Visa Inc. a key part of the Vanguard FTSE Social Index Fund. 2. Alphabet Inc. (NASDAQ:GOOG) Hedge Fund Holders: 209 Analyst Price Target: $130 Alphabet Inc. is famous for investing heavily into the ESG space and environment-related projects. 1. Microsoft Corporation (NASDAQ:MSFT) Hedge Fund Holders: 259 Analyst Price Target: $304 Microsoft Corporation has secured solid ESG ratings from several independent agencies because of its investments in the ESG space and sustainable business practices.” End quotes ------------------------------------------------------------- 2) Socially Responsible Stocks To Buy Now, an article that might interest many of you. It's titled Top Infrastructure Stocks - From An Engineer's Perspective, by Financial Engineering. Seen on seekingalpha.com. Here're some comments from the article. “1. American Tower Corporation (AMT) (Is) one of the largest global players in physical communications assets, most notably in macro cell towers and now data centers… The critical necessity for American Tower Corporation's assets will be at the heart of what is being dubbed as ‘Industrial Revolution 4.0' which is being discussed in regards to 5G and the Internet of Things, IoT… With the implementation of 5G and IoT we have the capability to significantly reduce traffic accidents, drastically improve manufacturing operations for greater flexibility in meeting global demands, and greatly improve our efficient use of resources with improved distribution networks of energy sources. 2. Union Pacific Corporation (UNP) Train operations have greatly improved in recent years through a revolutionary change in the approach to rail operations known as precision scheduled railroading (or PSR)… the benefits of PSR are significant to rail operations… PSR changed the focus of traditional rail operations from full train operations to individual train car operations… In a recent government report it is evidenced that PSR has led to a drastic decrease in operating ratios (operating expenses as a proportion of revenues) from 2011-2021… 3. DTE Energy (DTE). The main reason for including this company among the most important is due to the increasing electrification of our world… The vast majority of DTE's revenues are derived from its 2.2 million electric customer connections, the undisputed leader in the state of Michigan. … Detroit (Michigan) automakers own roughly 10-15% of global market share for vehicle sales and closer to 40% of the United States market share. If DTE is successfully able to expand and sufficiently meet the energy demands of the EV ramp-up in Detroit it will be pivotal in proving the viability of EV adoption not just in the United States but for the rest of the world as well… While each of these companies may not provide home run returns witnessed by tech in the past several decades, I'd be surprised if they do not provide solid, healthy returns and stability to a portfolio. If these corporations and their peers suffer substantial losses or fail in the near future, we most likely will have bigger concerns as a society than the performance of these stocks.” End quotes. ------------------------------------------------------------- 3) Socially Responsible Stocks To Buy A favorite of older ethical investors is utility stocks for their stability of returns. This is a good piece about them. It's titled Top Utilities Stocks for May 2023, by Noah Bolton. Article on investopedia.com. Here's some of what Mr. Bolton says about his picks. “These are the utilities stocks with the lowest 12-month trailing price-to-earnings (P/E) ratio. Because profits can be returned to shareholders in the form of dividends and buybacks, a low P/E ratio shows that you're paying less for each dollar of profit generated. Enel Chile S.A. (ENIC): Enel is a Chilean-based electricity provider. The company creates electricity from solar, wind, and geothermal power plants… 12-Month Trailing P/E Ratio 2.8. Brookfield Renewable Corp. (BEPC): Brookfield Renewable owns and operates pure-play renewable energy facilities focusing on wind, solar, and hydroelectric power. Brookfield Renewable and EIG Consortium entered a binding agreement in March to acquire 100% of Origin Energy Ltd.'s energy markets business, ‘Australia's largest integrated power generator and energy retailer…' 12-Month Trailing P/E Ratio 4.2. Pampa Energia S.A. (PAM): Pampa Energia is an integrated energy company based in Argentina operating hydroelectric plants, thermal plants, and wind farms. The company also explores and produces natural gas, oil, and various petrochemicals… 12-Month Trailing P/E Ratio 4.3. Fastest-Growing Utilities Stocks These are the top utilities stocks as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly year-over-year (YOY) percentage revenue growth and most recent quarterly YOY earnings-per-share (EPS) growth… Altus Power Inc. (AMPS): Altus Power is a clean electrification company that services commercial, industrial, and public industries. At the end of 2022, Altus Power reached an agreement with True Green Capital Management LLC to acquire 220 MW of solar assets for $293 million… EPS Growth 600%. Revenue Growth 24%. Cadiz Inc. (CDZI): Cadiz is a water treatment company that offers clean water resources for agricultural development. Note Cadiz doesn't have an EPS growth figure… because the company reported negative EPS in the most recent quarter… Revenue Growth 304%. Capital Power Corp. (CPX.TO): Capital Power owns and operates 29 renewable energy facilities located throughout North America… Net income in the first quarter more than doubled from the year before… EPS Growth 148. Revenue Growth 153%. Utilities Stocks With the Most Momentum Genie Energy Ltd. (GNE): Genie is an energy provider that supplies electricity and natural gas for residential and business customers. The company also operates a solar energy business segment. In late March, Genie Renewables acquired the rights to a 6.25-megawatt solar generation site in upstate New York. Genie's revenue increased 23% year-over-year in the first quarter of 2023… 12-Month Trailing Total Return 129%. Cadiz Inc.: See company description (previously)… 12-Month Trailing Total Return 129%. Enel Chile S.A.: See company description (previously)… 12-Month Trailing Total Return 118%.” End quotes ------------------------------------------------------------- 4) Socially Responsible Stocks To Buy Lastly, we have this recommendation titled 3 Sustainable Investing Stocks to Buy for Socially Responsible Gains by Joel Baglole. Found it on investorplace.com. Now a few comments by him. “1. General Electric (NYSE:GE) The company is pushing further into renewable energy, namely with GE Vernova… GE Vernova develops wind turbines, hydropower generation and energy storage solutions. GE stock has gained 73% in the past 12 months, including a 56% increase this year. 2. Ford Motor (NYSE:F) Ford Motor which is spending more than $50 billion in an effort to produce 2 million electric vehicles a year by the end of 2026… And the company pays a quarterly dividend of 15 cents a share for a yield above 5%. 3. Albemarle (NYSE:ALB) (Is) the largest producer of lithium for EV batteries in the world… Over the past five years, Albemarle stock has gained 78%. In the past 12 months, however, the company's share price has come down 10%. This is mainly due to shifting demand in China, where the country's electric vehicle production has been repeatedly interrupted due to Covid-19 lockdowns.” End quotes. ------------------------------------------------------------- Other Honorable Mention – not in any order 1. Title: Atlantica Sustainable Infrastructure: Revolutionizing the Energy Industry with Sustainable Investments on beststocks.com. By Roberto Liccardo. 2. Title: This solar energy tech stock could surge 50%, Guggenheim says on cnbc.com. By Hakyung Kim. 3. Title: 3 Sustainable Investing Stocks to Buy on investorplace.com. By Joel Baglole. 4. Title: Top Alternative Energy Stocks for Q2 2023 on investopedia.com. By Zaw Thiha Tun. 5. Title: 3 Alternative Energy Stocks to Watch Amid Insufficient Hydrogen Funding on zacks.com. By Aparajita Dutta. 6. Title: Water and investing – the risks, opportunities and why it matters on www.hl.co.uk. By Laura Hoy. 7. Title: 7 Alternative Energy Stocks to Watch in 2023 on investorplace.com. By Muslim Farooque. ------------------------------------------------------------- Ending Comment Well, these are my top news stories with their stock and fund tips -- for this podcast titled: “.” Now, please be sure to click the like and subscribe buttons on Apple Podcasts, Google Podcasts, or wherever you download or listen to this podcast. That helps bring these podcasts to others like you. And please click the share buttons to share this podcast with your friends and family. Let's promote ethical and sustainable investing as a force for hope and prosperity in these terribly troubled times! Contact me if you have any questions. Thank you for listening. Talk to you next on June 2nd. And, again, look at my newly totally revised website at investingforthesoul.com! Bye for now. © 2023 Ron Robins, Investing for the Soul
If you are an aspiring broker or even an investor who wants to see what it takes to be a top broker and how to separate yourself from the pack, this show is for you. We sit down and talk with fellow broker, David Gellner, of CPX who talks about his daily routine, what it takes to compete at a high level and how he prepares himself for this daily. We also talk about what the most important part of suceeding in brokerage is and ways you can elevate your brokerage game. You can reach David directly at dgellner@cpxone.com Enjoy the show!
Featuring perspectives from Drs Courtney DiNardo and Mark Levis, including the following topics: Introduction (0:00) Case: A man in his early 80s with newly diagnosed acute myeloid leukemia (AML) with significant comorbidities receives decitabine/venetoclax — Rebecca L Olin, MD, MSCE (7:36) Cases: A man in his mid 50s after 7 + 3 and allogeneic stem cell transplantation (SCT) presents with myeloid sarcoma; a man in his late 70s after 7 + 3 and allogeneic SCT presents with myeloid sarcoma — Spencer H Bachow, MD and Ranju Gupta, MD (12:16) Case: A man in his late 30s with core binding factor AML after induction CLAG-M with gemtuzumab ozogamicin followed by high-dose cytarabine x 4 — Anna Halpern, MD (18:10) Case: A woman in her mid 60s with newly diagnosed del(5q) AML with monocytic differentiation and multiple mutations (GATA2, BCOR, NF1 and RUNX1) receives azacitidine and venetoclax — Bhavana (Tina) Bhatnagar, DO (31:05) Selection of Therapy for Patients with AML (35:20) Cases: A man in his early 50s with therapy-related AML with an MLL mutation who receives CPX-351; a man in his early 70s with secondary AML with an IDH mutation — Amany R Keruakous, MD, MS and Priya Rudolph, MD, PhD (41:42) Case: A man in his early 70s with recurrent AML with an IDH2 mutation receives enasidenib and develops differentiation syndrome/disease progression — Dr Halpern (50:00) CME information and select publications
Study showing the time from diagnosis of AML to the start of intensive treatment indicate that a treatment delay has no negative prognostic impact. https://ashpublications.org/blood/article/136/7/823/460669/Does-time-from-diagnosis-to-treatment-affect-the RATIFY clinical trial showing the addition of midostaurin (FLT3 inhibitor) to 7+3 chemotherapy for AML https://www.nejm.org/doi/full/10.1056/nejmoa1614359 Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the European LeukemiaNet (ELN) https://ashpublications.org/blood/article/140/12/1345/485817/Diagnosis-and-management-of-AML-in-adults-2022 ASH 2022 abstract presenting Daunorubicin 60 Vs 90 mg/m2 https://ash.confex.com/ash/2022/webprogram/Paper157126.html ALFA-0701. The addition of gemtuzumab ozogamicin, an anti-CD33 antibody conjugate, to the standard treatment for patients with acute myeloid leukemiahttps://www.thelancet.com/article/S0140-6736(12)60485-1/fulltext Quizartinib data presented at EHA 2022 https://library.ehaweb.org/eha/2022/eha2022-congress/356965/harry.erba.quizartinib.prolonged.survival.vs.placebo.plus.intensive.induction.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2233%2Amarker%3D1749%2Afeatured%3D17676 International Consensus Classification (ICC) of Myeloid Neoplasms and Acute Leukemiashttps://ashpublications.org/blood/article/140/11/1200/485730/International-Consensus-Classification-of-Myeloid The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasmshttps://www.nature.com/articles/s41375-022-01613-1 CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemiahttps://ascopubs.org/doi/10.1200/JCO.2017.77.6112?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remissionhttps://www.nejm.org/doi/full/10.1056/NEJMoa2004444
You don't need to be a creative or an entrepreneur to share the human calling to make culture. --- Here at CPX, we've been raving about Andy Crouch's work on technology lately. But in this Life & Faith conversation, we revisit Andy's earlier work – especially his influential first book Culture Making: Recovering our Creative Calling. Andy tells us why he believes all humans are called to be culture makers: people who make culture or who are drawn to make something of the world. This creative calling is for everyone, he says, not just the creatives or the entrepreneurs among us. We also sample Andy's thoughts about Christianity in the United States and get into the weeds of why we're so down on power these days, or why we suspect that an influential person or institution will be corrupted by power. As Andy explains, the problem isn't so much power, but the way powerful people and organisations refuse vulnerability. “True power always involves an element of vulnerability – if I want to bring something into being in the world that will have any kind of life to it,” Andy said. “But the moment you create life, you take a risk. So all creative power, which I would see as the deepest form of power, involves an element of vulnerability.” -- Explore Culture Making: Recovering our Creative Calling Playing God: Redeeming the Gift of Power The Life We're Looking For: Reclaiming Relationship in a Technological World Strong and Weak: Embracing a Life of Love, Risk, and True Flourishing Listen to Andy Crouch's Richard Johnson Lecture Disconnected: Why Technology Keeps Failing Us
Roman Catechism of Trent (RCT) p. 22-24 *** CPX 33 on the Eastern Rites of the Catholic Church: https://youtu.be/600fkzBHdBc Trinitarian Bible Apologetics from Dr. Taylor Marshall : The Trinity is one Substance and three divine Persons: Mt 28:19 – Baptism is Trinitarian “I baptize you in the name (singular) of the Father, and of Son, [...]
How to make a creepy animatronic crawling hand. It uses a glove from a halloween costume, outfitted with a servo motor and a Circuit Playground Express. This hand is designed to pull itself along the floor slowly, waiting until it finds a cold, dark spot, at which point it will stop and wait until temperature and light increase. (0:05) Learn guide here: https://learn.adafruit.com/crawling-hand-with-CPX-and-MakeCode Solder paste (0:43) So much testing! (0:59) Pick n place (1:36) #adafruit #manufacturing #nyc ----------------------------------------- Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------
Theologian John Swinton was Chaplain to the Queen in Scotland. He spoke to Life & Faith on the day she died. --- John Swinton has been many things in his life: Mental Health Nurse, Presbyterian minister, academic and author. He was also Chaplain to the Queen in Scotland, a role his mother was especially proud of! On the morning he was due to come into the CPX studio news came through that Queen Elizabeth II had died. We talked about the Queen, her faith, and the role of Chaplain, that John briefly played. What made the death of this 96-year-old woman so profound for so many people? This topic led to a broader discussion about the caring professions, and spiritual care as a crucial part of any wholistic approach to true health. “... the way you learn how to be a decent person is by looking at decent people. And she always strikes me as a decent person that I have learned a lot from, even though … from a distance until relatively recently.” --- Explore some of John Swinton's books: Dementia: Living in the Memories of God. A Graceful Embrace: Theological Reflections on Adopting Children Finding Jesus in the Storm: The Spiritual Lives of Christians with Mental Health Challenges
Prototyping NeoTrellis M4 Mainboard time lapse (0:03) https://www.adafruit.com/product/3938 Checking the correct orientation of LEDs (0:17) Making LED Charlieplexed Matrix (0:32) https://www.adafruit.com/product/2947 Animated candle flame using 15x7 CharliePlex LED Matrix Display FeatherWing (1:09) https://learn.adafruit.com/animated-flame-pendant https://www.adafruit.com/product/3163 Testing the CRICKIT for CPX (1:30) https://www.adafruit.com/product/3093 Testing the CRICKIT HAT (1:48) https://www.adafruit.com/product/3957 Construction time lapse (2:04) Q&A Assembling one board in two pick and place machines (2:26) #adafruit #manufacturing #nyc ----------------------------------------- Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------
Featuring perspectives from Dr Richard Stone, including the following topics: Introduction: RATIFY trial in perspective (0:00) Treatment with FLT3 inhibitors (7:00) Anti-CD47 antibody: Magrolimab (23:04) Anti-TIM-3 antibody: Sabatolimab (31:23) CAR T-cell therapy for acute myeloid leukemia (34:53) Targeted therapy with IDH inhibitors (37:31) New myelodysplastic syndromes classification system (41:20) Hypomethylating agents/venetoclax (45:11) CPX-351 (49:14) Other key data sets (50:59) CME information and select publications
Reviewing Golf Pride's newest grip, the CPX. The CPX is soft, yet with great traction. The EXO Diamond pattern helps golfers by providing a larger contact patch for better control. Also touching on some tinkering I have done, or plan to do, to a bunch of my clubs.
Brett, Mark, and Corey welcome returning guest Chris Bright of Collector Part Exchange to discuss CPX's first year in business, expanding into interesting new areas, who their customers are, the success of their auctions, and what the future holds. In the news, Hagerty reminds us of car trivia you should know, Buick has a sleek new concept car, and Shelby American debuts a car that never was, but should have been. All this and much more in this week's Driven Radio Show! See acast.com/privacy for privacy and opt-out information.
A clinical investigator think tank and enduring multimedia activity with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and Eunice Wang, including the following topics: Introduction to therapy-related Acute Myeloid Leukemia (AML) (0:00) Treatment of AML evolving from prior MDS (12:27) Treatment of secondary AML in a patient ineligible for intensive therapy (29:41) Treatment for a patient with secondary AML with an IDH mutation (40:56) Long-term follow-up of CPX- 351 in patients with secondary AML (46:27) Potential role of venetoclax in combination with intensive chemotherapy regimens (52:54) Treatment for younger patients with secondary AML (58:46) Treatment of secondary AML with a FLT3 mutation (1:03:59) Data with CPX-351 in combination with targeted agents (1:08:30) Refractory disease versus differentiation syndrome from IDH inhibitors (1:19:20) Emerging data with menin inhibitors (1:28:13) Treatment of secondary AML evolving from prior MPN (1:31:52) Treatment of secondary AML with core binding factor (1:53:14) CME information and select publications
Catechism of Pope St. Pius X (CPX) p.131-135 Q/A 15-26. **** CPX 33 on the Eastern Rites: https://www.youtube.com/watch?v=600fkzBHdBc&t=1s Fr. Z on fasting expected of Roman Catholics in 1873 in Newark, NJ: https://wdtprs.com/2018/03/what-would-your-lent-have-been-like-in-1873/ Catechism of the Council of Trent: https://www.amazon.com/Catechism-Council-Trent/dp/089555884X/ref=sr_1_3?crid=3374R7MJFFT3C&keywords=catechism+of+trent&qid=1645990154&sprefix=catechism+of+tren%2Caps%2C115&sr=8-3